Literature DB >> 10721514

Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.

D A Stevens1, D W Denning, S Shatsky, R W Armstrong, J D Adler, B H Lewis.   

Abstract

Cryptococcosis as a complication of the immunocompromised host has dramatically increased in frequency since the start of the AIDS epidemic. This trend has heightened awareness of the complications of cryptococcal meningitis; of these, intracranial hypertension is common, severe, and life-threatening, as exemplified by three cases in our institutions presented here in detail. An aggressive approach to management of this complication has not been the standard of care, but neurosurgical interventional studies combined with physiologic observations suggest early intervention may reduce the devastating morbidity and mortality.

Entities:  

Mesh:

Year:  1999        PMID: 10721514     DOI: 10.1023/a:1007031514495

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

2.  Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types.

Authors:  B M Borgbjerg; F Gjerris; M J Albeck; J Hauerberg; S E Børgesen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  The use of indomethacin to treat acute rises of intracranial pressure and improve global cerebral perfusion in a child with head trauma.

Authors:  R Imberti; G Bellinzona; M Ilardi; P Bruzzone; P Pricca
Journal:  Acta Anaesthesiol Scand       Date:  1997-04       Impact factor: 2.105

4.  Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis.

Authors:  E Mylonakis; N A Merriman; J D Rich; T P Flanigan; B C Walters; K T Tashima; M D Mileno; C M van der Horst
Journal:  Diagn Microbiol Infect Dis       Date:  1999-06       Impact factor: 2.803

Review 5.  Fungal infections in solid organ transplant recipients.

Authors:  S Hadley; A W Karchmer
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

Review 6.  Itraconazole in cyclodextrin solution.

Authors:  D A Stevens
Journal:  Pharmacotherapy       Date:  1999-05       Impact factor: 4.705

7.  The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis.

Authors:  R A Seaton; N Verma; S Naraqi; J P Wembri; D A Warrell
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jan-Feb       Impact factor: 2.184

Review 8.  Malignant cerebral edema and intracranial hypertension.

Authors:  W E Bingaman; J I Frank
Journal:  Neurol Clin       Date:  1995-08       Impact factor: 3.806

9.  Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus.

Authors:  L M Tang
Journal:  Surg Neurol       Date:  1990-05

10.  Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.

Authors:  P K Sharkey; J R Graybill; E S Johnson; S G Hausrath; R B Pollard; A Kolokathis; D Mildvan; P Fan-Havard; R H Eng; T F Patterson; J C Pottage; M S Simberkoff; J Wolf; R D Meyer; R Gupta; L W Lee; D S Gordon
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

View more
  7 in total

1.  Cryptococcal Meningitis.

Authors:  Lourdes Irizarry
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

Review 2.  Management of Cryptococcus gattii meningoencephalitis.

Authors:  Carlos Franco-Paredes; Tanea Womack; Teri Bohlmeyer; Brenda Sellers; Allison Hays; Kalpesh Patel; Jairo Lizarazo; Shawn R Lockhart; Wajid Siddiqui; Kieren A Marr
Journal:  Lancet Infect Dis       Date:  2014-11-26       Impact factor: 25.071

3.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

4.  Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus.

Authors:  Sruti S Velamakanni; Nathan C Bahr; Abdu K Musubire; David R Boulware; Joshua Rhein; Henry W Nabeta
Journal:  Med Mycol Case Rep       Date:  2014-08-11

5.  Low diversity Cryptococcus neoformans variety grubii multilocus sequence types from Thailand are consistent with an ancestral African origin.

Authors:  Sitali P Simwami; Kantarawee Khayhan; Daniel A Henk; David M Aanensen; Teun Boekhout; Ferry Hagen; Annemarie E Brouwer; Thomas S Harrison; Christl A Donnelly; Matthew C Fisher
Journal:  PLoS Pathog       Date:  2011-04-28       Impact factor: 6.823

6.  Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis.

Authors:  Jia Liu; Zhuo-Lin Chen; Min Li; Chuan Chen; Huan Yi; Li Xu; Feng Tan; Fu-Hua Peng
Journal:  BMC Neurol       Date:  2018-05-01       Impact factor: 2.474

7.  Surgical treatment and operation time in human immunodeficiency virus-negative cryptococcal meningitis.

Authors:  Jie Zhao; Xiang Zhao; Shaobo Yang; Shuying Miao; Ying Liu
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.